-
1دورية أكاديمية
المؤلفون: Hinić S; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Human Genetics, Nijmegen, The Netherlands., Cybulski C; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands., Van der Post RS; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Pathology, Nijmegen, The Netherlands., Vos JR; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Human Genetics, Nijmegen, The Netherlands; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands., Schuurs-Hoeijmakers J; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Human Genetics, Nijmegen, The Netherlands., Brugnoletti F; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Human Genetics, Nijmegen, The Netherlands; Genomic Medicine, Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy., Koene S; Leiden University Medical Center, Department of Clinical Genetics, Leiden, The Netherlands., Vreede L; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Human Genetics, Nijmegen, The Netherlands., van Zelst-Stams WAG; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Human Genetics, Nijmegen, The Netherlands., Kets CM; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Human Genetics, Nijmegen, The Netherlands., Haadsma M; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Human Genetics, Nijmegen, The Netherlands., Spruijt L; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Human Genetics, Nijmegen, The Netherlands., Wevers MR; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Human Genetics, Nijmegen, The Netherlands., Evans DG; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands; The University of Manchester, Genomic Medicine, Division of Evolution, Infection and Genomic Sciences, Manchester, United Kingdom., Wimmer K; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria., Schnaiter S; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria., Volk AE; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands; Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Möllring A; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands; Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., de Putter R; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands; Center for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium., Soikkonen L; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands; Oulu University Hospital, Department of Clinical Genetics, Oulu, Finland., Kahre T; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands; Genetics and Personalized Medicine Clinic, Department of Laboratory Genetics, Tartu University Hospital, Tartu, Estonia; Department of Clinical Genetics, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia., Tooming M; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands; Genetics and Personalized Medicine Clinic, Department of Laboratory Genetics, Tartu University Hospital, Tartu, Estonia; Department of Clinical Genetics, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia., de Jong MM; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands; Department of Genetics, University Medical Center Groningen, Groningen, The Netherlands., Vaz F; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands; Instituto Português Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal., Mensenkamp AR; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Human Genetics, Nijmegen, The Netherlands., Genuardi M; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands; Genomic Medicine, Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy; Medical Genetics Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Lubinski J; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands., Ligtenberg M; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Human Genetics, Nijmegen, The Netherlands; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Pathology, Nijmegen, The Netherlands., Hoogerbrugge N; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Human Genetics, Nijmegen, The Netherlands; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands., de Voer RM; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Human Genetics, Nijmegen, The Netherlands; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands. Electronic address: richarda.devoer@radboudumc.nl.
المصدر: Genetics in medicine : official journal of the American College of Medical Genetics [Genet Med] 2024 May; Vol. 26 (5), pp. 101101. Date of Electronic Publication: 2024 Feb 13.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 9815831 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0366 (Electronic) Linking ISSN: 10983600 NLM ISO Abbreviation: Genet Med Subsets: MEDLINE
مواضيع طبية MeSH: Checkpoint Kinase 2*/genetics , Genetic Predisposition to Disease* , Germ-Line Mutation*/genetics , Neoplasms*/genetics, Adult ; Female ; Humans ; Male ; Middle Aged ; Alleles ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Colorectal Neoplasms/genetics ; Colorectal Neoplasms/pathology ; Exome Sequencing/methods ; Phenotype ; Prostatic Neoplasms/genetics ; Prostatic Neoplasms/pathology
-
2دورية أكاديمية
المؤلفون: Gori S; Oncology Department, IRCCS Sacro Cuore Don Calabria, Negrar, Verona, Italy., Barberis M; Pathology Unit, European Institute of Oncology, Milan, Italy., Bella MA; Medical Oncology Unit, University Hospital of Parma, Italy., Buttitta F; Center of Predictive Molecular Medicine, Center for Excellence on Aging and Translational Medicine, University of Chieti-Pescara, Italy., Capoluongo E; Institute of Biochemistry & Clinical Biochemistry, Catholic University of the Sacred Heart, Rome, Italy., Carrera P; Unit of Genomics for Diagnosis of Human Pathologies, Division of Genetics & Cell Biology, & Laboratory of Clinical Molecular Biology, IRCCS, Ospedale San Raffaele, Milan, Italy., Colombo N; European Institute of Oncology 'IEO', Milan, Italy., Cortesi L; Department of Oncology, Hematology & Respiratory Diseases, University Hospital of Modena, Italy., Genuardi M; Institute of Genomic Medicine, 'A Gemelli' School of Medicine, Catholic University of the Sacred Heart, Rome, Italy., Gion M; Regional Center for Biomarkers, Department of Clinical Pathology and Transfusion Medicine, Azienda ULSS3 Serenissima, Venice, Italy., Guarneri V; Department of Surgery, Oncology & Gastroenterology, University of Padova, Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy., Incorvaia L; Department of Surgical, Oncological & Oral Sciences, Section of Medical Oncology, University of Palermo, Italy., La Verde N; Department of Oncology, ASST Fatebenefratelli Sacco PO Fatebenefratelli, Milan, Italy; Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Lorusso D; Università Cattolica del Sacro Cuore, Rome, Italy., Marchetti A; Center of Predictive Molecular Medicine, University-Foundation, CeSI Biotech Chieti, Italy., Marchetti P; Clinical & Molecular Medicine Department, Sapienza University, Rome, Italy., Normanno N; Cell Biology & Biotherapy Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori 'Fondazione Giovanni Pascale' - IRCCS Naples, Italy., Pasini B; Department of Medical Science, University of Turin, Turin, Italy., Pensabene M; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy., Pignata S; Department of Urology and Gynecology, Istituto Nazionale Tumori 'Fondazione G. Pascale', Naples, Italy., Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Ricevuto E; Oncology Network ASL1 Abruzzo, Oncology Territorial Care Unit, Division of Medical Oncology, Department of Biotechnological & Applied Clinical Sciences, University of L'Aquila, Italy., Sapino A; Candiolo Cancer Institute-FPO-IRCCS, Candiolo, Turin, Italy; Department of Medical Sciences, University of Turin, Turin, Italy., Tagliaferri P; Department of Experimental & Clinical Medicine, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro, Italy., Tassone P; Translational Medical Oncology Unit, Department of Experimental and Clinical Medicine, Magna Græcia University and Cancer Center, Campus Salvatore Venuta, Catanzaro, Italy., Trevisiol C; Veneto Institute of Oncology IOV - IRCCS, Padua, Italy., Truini M; Pathological Anatomy Histology & Cytogenetics, Niguarda Cancer Center, Niguarda Ca' Granda Hospital, Milan, Italy., Varesco L; Unit of Hereditary Cancers, IRCCS AOU San Martino - IST, Genoa, Italy., Russo A; Department of Surgical, Oncological & Oral Sciences, Section of Medical Oncology, University of Palermo, Italy. Electronic address: antonio.russo@usa.net.
مؤلفون مشاركون: AIOM-SIGU-SIBIOC-SIAPEC-IAP Working Group
المصدر: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2019 Aug; Vol. 140, pp. 67-72. Date of Electronic Publication: 2019 May 25.
نوع المنشور: Journal Article; Practice Guideline
بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE
مواضيع طبية MeSH: Germ-Line Mutation* , Societies, Medical*, BRCA1 Protein/*genetics , BRCA2 Protein/*genetics , Genetic Testing/*standards , Ovarian Neoplasms/*genetics, Biochemistry ; Female ; Genetics ; Humans ; Italy ; Medical Oncology ; Ovarian Neoplasms/diagnosis
-
3دورية أكاديمية
المؤلفون: Vogelaar IP; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands., van der Post RS; Department of Pathology, Radboud university medical center, Nijmegen, The Netherlands., van Krieken JHJ; Department of Pathology, Radboud university medical center, Nijmegen, The Netherlands., Spruijt L; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands., van Zelst-Stams WA; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands., Kets CM; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands., Lubinski J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Teodorczyk U; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Aalfs CM; Department of Clinical Genetics, Academic Medical Centre, Amsterdam, The Netherlands., van Hest LP; Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands., Pinheiro H; Expression Regulation in Cancer Group, Instituto de Investigação e Inovação em Saúde, Porto, Portugal.; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal., Oliveira C; Expression Regulation in Cancer Group, Instituto de Investigação e Inovação em Saúde, Porto, Portugal.; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal.; Department of Pathology and Oncology, Faculty of Medicine, University of Porto, Al Prof Hernâni Monteiro, Porto, Portugal., Jhangiani SN; Human Genome Sequencing Center, Baylor College of Medicine, One Baylor Plaza, Houston, TX, USA.; Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX, USA., Muzny DM; Human Genome Sequencing Center, Baylor College of Medicine, One Baylor Plaza, Houston, TX, USA.; Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX, USA., Gibbs RA; Human Genome Sequencing Center, Baylor College of Medicine, One Baylor Plaza, Houston, TX, USA.; Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX, USA., Lupski JR; Human Genome Sequencing Center, Baylor College of Medicine, One Baylor Plaza, Houston, TX, USA.; Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX, USA., de Ligt J; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands., Vissers LELM; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands., Hoischen A; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands., Gilissen C; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands., van de Vorst M; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands., Goeman JJ; Department for Health Evidence, Radboud university medical center, Nijmegen, The Netherlands.; Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands., Schackert HK; Department of Surgical Research, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Ranzani GN; Department of Biology and Biotechnology, University of Pavia, Pavia, Italy., Molinaro V; Department of Biology and Biotechnology, University of Pavia, Pavia, Italy., Gómez García EB; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands., Hes FJ; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands., Holinski-Feder E; Medizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, München, Germany., Genuardi M; Institute of Genomic Medicine, Catholic University of the Sacred Heart, Rome, Italy., Ausems MGEM; Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands., Sijmons RH; Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Wagner A; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands., van der Kolk LE; Family Cancer Clinic, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Bjørnevoll I; Department of Medical Genetics and Pathology, St. Olavs University Hospital, Trondheim, Norway., Høberg-Vetti H; Western Norway Familial Cancer Center, Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway., van Kessel AG; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands., Kuiper RP; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands., Ligtenberg MJL; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands.; Department of Pathology, Radboud university medical center, Nijmegen, The Netherlands., Hoogerbrugge N; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands.
المصدر: European journal of human genetics : EJHG [Eur J Hum Genet] 2017 Nov; Vol. 25 (11), pp. 1246-1252. Date of Electronic Publication: 2017 Sep 06.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9302235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5438 (Electronic) Linking ISSN: 10184813 NLM ISO Abbreviation: Eur J Hum Genet Subsets: MEDLINE
مواضيع طبية MeSH: Exome* , Genetic Predisposition to Disease* , Germ-Line Mutation*, Genetic Testing/*methods , Stomach Neoplasms/*genetics, Adult ; Aged ; Antigens, CD ; Cadherins/genetics ; Early Detection of Cancer/methods ; Female ; Humans ; Male ; Middle Aged ; Sequence Analysis, DNA/methods ; Stomach Neoplasms/diagnosis
-
4دورية أكاديمية
المؤلفون: Resta N; Department of Biomedical Sciences and Human Oncology, Medical Genetics Unit, Aldo Moro, University of Bari, Italy. nicoletta.resta@uniba.it, Pierannunzio D, Lenato GM, Stella A, Capocaccia R, Bagnulo R, Lastella P, Susca FC, Bozzao C, Loconte DC, Sabbà C, Urso E, Sala P, Fornasarig M, Grammatico P, Piepoli A, Host C, Turchetti D, Viel A, Memo L, Giunti L, Stigliano V, Varesco L, Bertario L, Genuardi M, Lucci Cordisco E, Tibiletti MG, Di Gregorio C, Andriulli A, Ponz de Leon M
مؤلفون مشاركون: AIFEG
المصدر: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2013 Jul; Vol. 45 (7), pp. 606-11. Date of Electronic Publication: 2013 Feb 15.
نوع المنشور: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 100958385 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3562 (Electronic) Linking ISSN: 15908658 NLM ISO Abbreviation: Dig Liver Dis Subsets: MEDLINE
مواضيع طبية MeSH: Germ-Line Mutation/*genetics , Pancreatic Neoplasms/*genetics , Peutz-Jeghers Syndrome/*genetics , Protein Serine-Threonine Kinases/*genetics , Uterine Cervical Neoplasms/*genetics, AMP-Activated Protein Kinase Kinases ; Adolescent ; Adult ; Aged ; Breast Neoplasms/epidemiology ; Breast Neoplasms/genetics ; Child ; Child, Preschool ; Cohort Studies ; Female ; Gastrointestinal Neoplasms/epidemiology ; Gastrointestinal Neoplasms/genetics ; Genetic Predisposition to Disease ; Genital Neoplasms, Female/epidemiology ; Genital Neoplasms, Female/genetics ; Humans ; Italy ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Neoplasms ; Pancreatic Neoplasms/epidemiology ; Peutz-Jeghers Syndrome/epidemiology ; Phenotype ; Retrospective Studies ; Risk Factors ; Sex Distribution ; Uterine Cervical Neoplasms/epidemiology ; Young Adult
-
5دورية أكاديمية
المؤلفون: Papi L; Medical Genetics Unit, Department of Clinical Physiopathology, University of Florence, Viale Pieraccini, 6, 50139 Florence, Italy., Putignano AL, Congregati C, Piaceri I, Zanna I, Sera F, Morrone D, Genuardi M, Palli D
المصدر: Familial cancer [Fam Cancer] 2010 Jun; Vol. 9 (2), pp. 181-5. Date of Electronic Publication: 2009 Sep 18.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Springer Country of Publication: Netherlands NLM ID: 100898211 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7292 (Electronic) Linking ISSN: 13899600 NLM ISO Abbreviation: Fam Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Breast Neoplasms/*genetics , Genetic Predisposition to Disease/*genetics , Germ-Line Mutation/*genetics , Nuclear Proteins/*genetics , Tumor Suppressor Proteins/*genetics, Age of Onset ; BRCA2 Protein/genetics ; Biomarkers, Tumor ; Breast Neoplasms/epidemiology ; Fanconi Anemia Complementation Group N Protein ; Female ; Humans ; Italy/epidemiology ; Male ; Mutation ; Pedigree ; Tumor Suppressor Proteins/metabolism
-
6دورية أكاديمية
المؤلفون: Russo A; Epidemiology Unit, San Carlo Hospital, Milan, Italy., Sala P, Alberici P, Gazzoli I, Radice P, Montefusco C, Torrini M, Mareni C, Fornasarig M, Santarosa M, Viel A, Benatti P, Pedroni M, de Leon MP, Lucci-Cordisco E, Genuardi M, Messerini L, Stigliano V, Cama A, Curia MC, de Lellis L, Signoroni S, Pierotti MA, Bertario L
المصدر: Tumori [Tumori] 2009 Nov-Dec; Vol. 95 (6), pp. 731-8.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Sage Publications Country of Publication: United States NLM ID: 0111356 Publication Model: Print Cited Medium: Print ISSN: 0300-8916 (Print) Linking ISSN: 03008916 NLM ISO Abbreviation: Tumori Subsets: MEDLINE
مواضيع طبية MeSH: Germ-Line Mutation*, Adaptor Proteins, Signal Transducing/*genetics , Colorectal Neoplasms, Hereditary Nonpolyposis/*genetics , Colorectal Neoplasms, Hereditary Nonpolyposis/*pathology , MutS Homolog 2 Protein/*genetics , Nuclear Proteins/*genetics, Adult ; Aged ; DNA Mismatch Repair ; Female ; Humans ; Male ; Middle Aged ; MutL Protein Homolog 1 ; Neoplasm Staging ; Predictive Value of Tests ; Prognosis ; Proportional Hazards Models ; Survival Analysis
-
7دورية أكاديمية
المؤلفون: Papi L; Medical Genetics Unit, Department of Clinical Pathophysiology, University of Florence, Florence, Italy., Palli D, Masi L, Putignano AL, Congregati C, Zanna I, Marini F, Giusti F, Luzi E, Tonelli F, Genuardi M, Brandi ML, Falchetti A
المصدر: Cancer genetics and cytogenetics [Cancer Genet Cytogenet] 2009 Nov; Vol. 195 (1), pp. 75-9.
نوع المنشور: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Elsevier/North-Holland Country of Publication: United States NLM ID: 7909240 Publication Model: Print Cited Medium: Internet ISSN: 1873-4456 (Electronic) Linking ISSN: 01654608 NLM ISO Abbreviation: Cancer Genet Cytogenet Subsets: MEDLINE
مواضيع طبية MeSH: Genes, BRCA1* , Germ-Line Mutation*, Breast Neoplasms/*genetics , Multiple Endocrine Neoplasia Type 1/*genetics , Ovarian Neoplasms/*genetics , Proto-Oncogene Proteins/*genetics, Adult ; Female ; Humans
-
8دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
9
المؤلفون: Nicla La Verde, Fiamma Buttitta, Maria Angela Bella, Massimo Barberis, Ettore Capoluongo, Chiara Trevisiol, Pierosandro Tagliaferri, Enrico Ricevuto, Nicola Normanno, Nicoletta Colombo, Matilde Pensabene, Antonio Russo, Sandro Pignata, Anna Sapino, Domenica Lorusso, Liliana Varesco, Maurizio Genuardi, Lorena Incorvaia, Massimo Gion, Valentina Guarneri, Laura Cortesi, Pierfrancesco Tassone, Paolo Radice, Mauro Truini, Paolo Marchetti, Stefania Gori, Antonio Marchetti, Barbara Pasini, Paola Carrera
المساهمون: Gori, Stefania, Barberis, Massimo, Bella, Maria Angela, Buttitta, Fiamma, Capoluongo, Ettore, Carrera, Paola, Colombo, Nicoletta, Cortesi, Laura, Genuardi, Maurizio, Gion, Massimo, Guarneri, Valentina, Incorvaia, Lorena, La Verde, Nicla, Lorusso, Domenica, Marchetti, Antonio, Marchetti, Paolo, Normanno, Nicola, Pasini, Barbara, Pensabene, Matilde, Pignata, Sandro, Radice, Paolo, Ricevuto, Enrico, Sapino, Anna, Tagliaferri, Pierosandro, Tassone, Pierfrancesco, Trevisiol, Chiara, Truini, Mauro, Varesco, Liliana, Russo, Antonio, Gori, S., Barberis, M., Bella, M. A., Buttitta, F., Capoluongo, Ettore Domenico, Carrera, P., Colombo, N., Cortesi, L., Genuardi, M., Gion, M., Guarneri, V., Incorvaia, L., La Verde, N., Lorusso, D., Marchetti, A., Marchetti, P., Normanno, N., Pasini, B., Pensabene, M., Pignata, S., Radice, P., Ricevuto, E., Sapino, A., Tagliaferri, P., Tassone, P., Trevisiol, C., Truini, M., Varesco, L., Russo, A., Gori, S, Barberis, M, Bella, M, Buttitta, F, Capoluongo, E, Carrera, P, Colombo, N, Cortesi, L, Genuardi, M, Gion, M, Guarneri, V, Incorvaia, L, La Verde, N, Lorusso, D, Marchetti, A, Marchetti, P, Normanno, N, Pasini, B, Pensabene, M, Pignata, S, Radice, P, Ricevuto, E, Sapino, A, Tagliaferri, P, Tassone, P, Trevisiol, C, Truini, M, Varesco, L, Russo, A
مصطلحات موضوعية: 0301 basic medicine, Oncology, Genetic testing, endocrine system diseases, Settore MED/03 - GENETICA MEDICA, Medical Oncology, Biochemistry, chemistry.chemical_compound, 0302 clinical medicine, Germline mutation, PARP inhibitors, Trabectedin, Societies, Medical, Ovarian Neoplasms, medicine.diagnostic_test, BRCA1 Protein, Hematology, female genital diseases and pregnancy complications, Italy, 030220 oncology & carcinogenesis, Female, medicine.drug, Human, medicine.medical_specialty, Genetic counseling, Olaparib, 03 medical and health sciences, Genetic, Somatic mutations, Ovarian cancer, Medical, Internal medicine, BRCA1, BRCA2, Germline mutations, BRCA2 Protein, Genetic Testing, Genetics, Humans, Germ-Line Mutation, medicine, Genetic predisposition, Rucaparib, business.industry, Somatic mutation, Ovarian Neoplasm, Cancer, medicine.disease, 030104 developmental biology, PARP inhibitor, chemistry, Societies, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::942108ee20348ca4ec8b28d92ca4333a
http://hdl.handle.net/10447/437173 -
10
المؤلفون: Ettore Capoluongo, Sandro Pignata, Paola Carrera, Enrico Ricevuto, Maurizio Genuardi, Paolo Radice, Antonio Russo, Nicoletta Colombo, Carmine Pinto, Stefania Gori, Barbara Pasini, Paolo Marchetti, Nicola Normanno, Valentina Guarneri, Laura Cortesi, Antonio Marchetti, Mauro Truini, Maria Angela Bella, Pierosandro Tagliaferri, Pierfrancesco Tassone, Gaetano De Rosa, Francesca Fenizia, Claudio Clemente, Liliana Varesco
المساهمون: Pinto, Carmine, Bella, Maria Angela, Capoluongo, Ettore, Carrera, Paola, Clemente, Claudio, Colombo, Nicoletta, Cortesi, Laura, DE ROSA, Gaetano, Fenizia, Francesca, Genuardi, Maurizio, Gori, Stefania, Guarneri, Valentina, Marchetti, Antonio, Marchetti, Paolo, Normanno, Nicola, Pasini, Barbara, Pignata, Sandro, Radice, Paolo, Ricevuto, Enrico, Russo, Antonio, Tagliaferri, Pierosandro, Tassone, Pierfrancesco, Truini, Mauro, Varesco, Liliana, Pinto, C., Bella, M., Capoluongo, E., Carrera, P., Clemente, C., Colombo, N., Cortesi, L., De Rosa, G., Fenizia, F., Genuardi, M., Gori, S., Guarneri, V., Marchetti, A., Marchetti, P., Normanno, N., Pasini, B., Pignata, S., Radice, P., Ricevuto, E., Russo, A., Tagliaferri, P., Tassone, P., Truini, M., Varesco, L., Pinto, C, Bella, M, Capoluongo, E, Carrera, P, Clemente, C, Colombo, N, Cortesi, L, De Rosa, G, Fenizia, F, Genuardi, M, Gori, S, Guarneri, V, Marchetti, A, Marchetti, P, Normanno, N, Pasini, B, Pignata, S, Radice, P, Ricevuto, E, Russo, A, Tagliaferri, P, Tassone, P, Truini, M, Varesco, L
مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, Genes, BRCA2, Genes, BRCA1, Brca testing, BRCA1, BRCA2, genetic testing, germline mutations, ovarian cancer, PARP inhibitors, somatic mutations, Settore MED/03 - GENETICA MEDICA, 0302 clinical medicine, Clinical decision making, Informed consent, somatic mutation, BRCA1, BRCA2, genetic testing, germline mutations, somatic mutations, ovarian cancer, PARP inibitors, Disease management (health), Ovarian Neoplasms, Tumor, Informed Consent, medicine.diagnostic_test, Disease Management, General Medicine, Prognosis, Biomarkers, Tumor, Clinical Decision-Making, Female, Genetic Variation, Germ-Line Mutation, Humans, Mutation, Genetic Testing, germline mutation, 030220 oncology & carcinogenesis, Human, medicine.medical_specialty, Prognosi, MEDLINE, 03 medical and health sciences, PARP inibitors, Internal medicine, medicine, Genetic testing, Gynecology, business.industry, Ovarian Neoplasm, medicine.disease, 030104 developmental biology, PARP inhibitor, Genes, Ovarian cancer, business, Biomarkers
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eb9b4ad22ad35cde975131fad7a5a30
http://hdl.handle.net/11577/3362422